Scopus BioPharma increases authorized common shares via charter amendment

Scopus BioPharma Inc.

Stockholders approved increase in authorized shares of common stock on August 10, 2023.
Certificate of Amendment filed with Delaware Secretary of State, effective August 14, 2023.
Amendment attached as Exhibit 3.1 to the 8-K.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Scopus BioPharma Inc.: Increased number of authorized shares of common stock (effective 2023-08-14).

Change: charter amendment
Effective: 2023-08-14

Exact text from the filing

The Company filed a Certificate of Amendment (the “Amendment”) with the Secretary of State of Delaware to effectuate the Authorized Share Increase, which became effective in Delaware on August 14, 2023.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001104659-23-093554

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.